Psychemedics launches Advanced 5-Panel Drug Screen

Psychemedics announces the launch of the Advanced 5-Panel Drug Screen. The company said, “This offering will transform the way organizations safeguard their workplaces, shifting the spotlight from marijuana to the paramount threat of fentanyl. Complemented by the detection of cocaine, opioids, PCP, and amphetamines, the advanced panel is a leap forward in drug screening technology.”